Comments
Dr Reddy’s Laboratories Ltd has launched Esomeprazole Magnesium Delayed-Release Capsules in the US market. This is an over-the-counter (OTC) therapeutic equivalent generic version of Nexium capsules.
Esomeprazole Magnesium Delayed-Release Capsules is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days in a week in adults.
"This launch continues to demonstrate our R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market,” Milan Kalawadia, Vice President and Head, US OTC and Speciality Rx businesses, Dr. Reddy’s Laboratories, said in a release.
The combined market of Nexium capsules and private label OTC Esomeprazole Magnesium products had US sales of approximately $311 million for the most recent 12 months ended May 2018, according to IRI.
The company shares were trading up by 1.71 per cent at Rs 2,065.65 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.